Euro-Med Laboratories Phil., Inc. (PSE:EURO)
Philippines flag Philippines · Delayed Price · Currency is PHP
1.370
+0.100 (7.87%)
At close: Nov 17, 2026

PSE:EURO Financials Overview

Millions PHP. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7,1366,8685,7965,2644,2243,587
Revenue Growth
6.40%18.50%10.11%24.62%17.75%-6.31%
Gross Profit
2,5612,4392,0121,8941,4931,438
Operating Income
950.33899.65669.03652.58440.44411.1
Net Income
525.88470.3337.68289.95199.89169.05
Earnings Per Share
0.120.110.080.070.050.04
EPS Growth
32.20%37.50%13.46%45.05%21.52%-20.00%

Revenue by Segment

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Manufacturing Pharmaceutical Products
5,0724,3984,0323,1622,688
Providing Health and Other Care Services
990.92655.68493.87453.8610.51
Development and Operation of Quick Service Restaurant
964.66887.13823.09661.44344.06
Elimination
-158.97-144.31-85.21-53.22-55.62
Total
6,8685,7965,2644,2243,587

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,7561,5181,0911,083806.31727.89
Total Debt
4,2534,3124,2934,0393,6813,421
Net Cash (Debt)
-2,497-2,794-3,202-2,956-2,874-2,693
Net Cash Growth
------
Net Cash Per Share
-0.59-0.68-0.78-0.72-0.70-0.65

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,129970.72246.81354.13148.23488.4
Capital Expenditures
-208.02-267.93-196.08-291.87-88.89-285.57
Free Cash Flow
920.57702.7850.7362.2659.35202.83
Free Cash Flow Growth
272.69%1285.29%-18.52%4.91%-70.74%-

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
35.89%35.52%34.71%35.98%35.35%40.08%
Operating Margin
13.32%13.10%11.54%12.40%10.43%11.46%
Pretax Margin
9.90%9.28%7.55%7.57%6.64%6.45%
Profit Margin
7.37%6.85%5.83%5.51%4.73%4.71%
FCF Margin
12.90%10.23%0.88%1.18%1.41%5.65%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.070-0.0700.0600.0350.020
Dividend Per Share Growth
7.14%-16.67%71.43%75.00%33.33%
Dividend Yield
5.11%-8.54%8.00%4.02%1.43%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.468.749.9910.6417.9034.06
P/FCF Ratio
6.125.8566.4749.5460.2828.38
PS Ratio
0.790.600.580.590.851.61